LIC bought 2,02,500 shares of Sun Pharma from the open market, amounting to a 0.008% stake, from the open market on January 13. With this, LIC's stake in the blue-chip pharma stock has jumped to 5.004% from 4.996% earlier.
1 min read14 Jan 2026Life Insurance Corporation of India has increased its stake in Voltas by over 2%, acquiring 67.44 lakh shares. This brings LIC's total stake to 7.089%. Voltas reported a significant profit drop due to weak demand and market conditions, with its stock still down 24.32% year-to-date.
2 min read24 Nov 2025Life Insurance Corporation of India (LIC) share price was down 0.74 per cent to ₹899 apiece on Thursday, November 6, ahead of its second quarter earnings announcement.
2 min read6 Nov 2025Life Insurance Corporation of India (LIC), on Tuesday, reaffirmed that it has neither issued nor received any of the documents referenced in the Washington Post report, which claimed that its investment decisions in the Adani Group were influenced by external factors.
1 min read29 Oct 2025JPMorgan has upgraded HDFC Life shares to ‘Overweight’ and raised target price to ₹980 apiece from ₹750 earlier. The brokerage firm also upgraded GIC shares to ‘Overweight’, with an increased target price of ₹480 per share from ₹197 earlier.
2 min read22 Sep 2025IDBI Bank divestment: Capital markets regulator, Sebi, approved the reclassification of LIC as a public shareholder in IDBI Bank on 23 August 2025. The classification status can be changed only if the company complies with THESE criterias.
2 min read24 Aug 2025Life Insurance Corp of India seeks better market valuation due to improved customer service and a stronger product portfolio, according to new CEO R. Doraiswamy. He anticipates that digital transformation initiatives will enhance LIC's standing ahead of a planned government stake sale.
7 min read12 Aug 2025LIC Stake Sale: Govt likely to sell minority stake in PSU-insurer
1 min read10 Jul 2025Zee's largest foreign investor Norges has backed the resolution. Proxy firm SES, which had earlier asked shareholders to reject the resolution, also supports it, improving the odds. But two other domestic proxy advisors, IiAS and InGovern, remain opposed.
3 min read8 Jul 2025LIC’s shareholding in Dr. Reddy’s Laboratories rose from 5.6% at the end of September 2024 to 6.5% by December 2024, and further to 7.19% as of March 2025, according to the latest shareholding pattern.
1 min read5 Jun 2025Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.